Silobreaker.com
360° SearchNetworkHot SpotsTrends
 
Advanced Search Options >>
Saturday, November 21, 2009 7:02 PM

Boston Scientific Corporation

Boston Scientific Corporation - Click to view image in its original context
Boston Scientific Corporation
Type: Company
Name: Boston Scientific Corporation
First Reported 11/20/2009 - Updated 12 hours ago - 7 Documents
Food and Drug Administration - Click to view 360-page
Food and Drug Administration
- US medical devices maker Boston Scientific Corporation (NYSE: BSX) said today it has received 510(k) clearance from the US Food and Drug Administration (FDA) and CE Mark approval to market its WallFlex Fully Covered Esophageal Stent for the treatment ... [Pharmacy Choice - 12 hours ago]
First Reported 21 hours ago - Updated 5 hours ago - 2 Documents
King Juan Carlos - Click to view image in its original context
King Juan Carlos
Medical products company , which has more than 1,200 employees working out of a 14-acre plant in Doral, is relocating its operation to Costa Rica over the next three years.Doral Mayor Juan Carlos Bermudez said he received a call from the Beacon Council ... [Philadelphia Business Journal - 5 hours ago]
First Reported 11/19/2009 - Updated 11/19/2009 - 1 Documents (in Internet & IT)
Clorox Company - Click to view 360-page
Clorox Company
Wall Street News Alert's 'stocks to watch' this morning are: Bio-Clean, Inc. (OTCBB: BOCL), Ford Motor Company (NYSE: F), The Clorox Company (NYSE: CLX) and Boston Scientific Corporation (NYSE: BSX).Yesterday, Bio-Clean, Inc. (OTCBB: BOCL) issued a press ... [PR-USA.net - 11/19/2009]
First Reported 11/20/2009 - Updated 11/20/2009 - 1 Documents
This site is owned and operated by Informa plc ('Informa') whose registered office is Mortimer House, 37-41 Mortimer Street, London, W1T 3JH. Registered in England and Wales. Number 3099067. UK VAT Group: GB 365 4626 36 ... [Clinica - 11/20/2009]
First Reported 11/19/2009 - Updated 11/19/2009 - 1 Documents
Medtronic Inc - Click to view image in its original context
Medtronic Inc
WASHINGTON -(Dow Jones)- The key health-care overhaul issue now facing medical-device companies is when they may have to start paying a collective $2 billion-per-year tax proposed in Congress.The amount itself now seems set and has been halved from an ... [CNN Money - 11/19/2009]
First Reported 11/19/2009 - Updated 11/19/2009 - 1 Documents
Natick-based medical device company Boston Scientific Corp. has for years given back to the community through the Boston Scientific Foundation, which supports local and national programs that improve lives in the areas of health and education for the ... [Mass High Tech - 11/19/2009]
First Reported 11/16/2009 - Updated 11/16/2009 - 1 Documents (in Politics)
Becton Dickinson and Company - Click to view image in its original context
Becton Dickinson and Company
AMR Research ranks healthcare companies on innovation By Nov. 16, 2009 » Last week AMR Research released its Healthcare Top 25, which ranks companies that have best demonstrated leadership in building supply chain excellence and innovation that ... [Industry Week - 11/16/2009]
First Reported 11/17/2009 - Updated 11/17/2009 - 1 Documents (in Internet & IT)
UPGRADES:Barclays upgrades Exxon Mobil Corp. (NYSE: XOM) from Equal Weight to Overweight and raised their price target from $90 to $92.Kaufman Bros. upgrades Palm, Inc. (NASDAQ: PALM) from Hold to Buy with a $16 price target. http://www.streetinsider ... [Street Insider - 11/17/2009]
First Reported 11/17/2009 - Updated 11/17/2009 - 1 Documents
Morgan Joseph initiates coverage on Boston Scientific (NYSE: BSX) with a Hold.Morgan analyst says, "The stock has traded between 9x-15x over the past two years at a discount to the comp group range of 13x-16x and currently trades at 16x 2009 consensus ... [Street Insider - 11/17/2009]
First Reported 11/18/2009 - Updated 11/18/2009 - 1 Documents
Nov 18 (Reuters) - :* UBS raises Boston Scientific Zimmer Holdings to buy fromneutral* UBS raises Abbott Laboratories price target to $61 from $57* UBS raises Baxter International Inc price target to $64 from $62* UBS raises Boston Scientific Corp price ... [Forbes.com - 11/18/2009]
First Reported 11/18/2009 - Updated 11/18/2009 - 1 Documents (in Internet & IT)
UBS upgrades Boston Scientific (NYSE: BSX) from Neutral to Buy. Price target increased to $10.To see all the upgrades/downgrades on shares of BSX, visit our Analyst Ratings page.Boston Scientific Corporation operates as a developer, manufacturer, and ... [Street Insider - 11/18/2009]
First Reported 11/06/2009 - Updated 11/07/2009 - 11 Documents
Boston Scientific Corporation (NYSE: BSX) today announced that it has reached an agreement in principle with the U.S. Department of Justice (DOJ) related to product advisories issued by its Guidant subsidiary in 2005. The alleged conduct and product sales ... [News-Medical.Net - 11/07/2009]

Quotes

...that many jobs, it's significant,'' said Nero, whose organization manages business recruitment and retention on behalf of the county government. "It's never a good thing when we're trying to promote a cluster in life sciences and you lose a company like Boston Scientific. It's just not good."
...Covered Esophageal Stents represents a tremendous milestone for Boston Scientific," said Michael Phalen, President, Boston Scientific Endoscopy. "This advanced line of esophageal stents is designed to improve the quality of life for the thousands of patients suffering from esophageal cancer. We are pleased that our entire WallFlex Stent family -- biliary, enteral and now esophageal -- is available in the U S , Europe and other strategic international markets. This underscores our mission to meet the high expectations of our customers and deliver a complete range of innovative treatment options to diagnose, palliate and treat patients with diseases of the gastrointestinal tract."
Morgan analyst says, "The stock has traded between 9x-15x over the past two years at a discount to the comp group range of 13x-16x and currently trades at 16x 2009 consensus EPS. We view the shares as being fully valued. Risks associated with the stock include the timing and success of clinical trials, new product launch timing, availability of reimbursement, litigation, and healthcare reform...Boston Scientific is a turnaround story, in our view, led by a new management team that is trying to increase gross margins with a combination of manufacturing rationalization, new products, and intensified marketing efforts. BSC is a big ship to turn, however...The drug eluting stent (DES) product mix is currently shifting from TAXUS to the newer PROMUS stent, which is supplied to BSC by Abbott Labs (NYSE: ABT). The good news is that having two stent platforms is helping the company preserve its market-leading position in drug eluting stents. The bad news is that the gross margin on a PROMUS stent is half that of the TAXUS, which is likely to pressure margins in the Cardiovascular business until the next-generation PROMUS Element is introduced."

More Content

All (536) | News (457) | Reports (0) | Blogs (65) | Audio/Video (0) | Fact Sheets (7)
sort by: Date | Relevance
Boston Scientific to leave Doral [Philadelphia Business Journal - 5 hours ago]
Boston Scientific gets FDA clearance, CE Mark f... [Pharmacy Choice - 12 hours ago]
WallFlex Esophageal Stent Gets FDA OK, CE Mark [EndoNurse - 19 hours ago]
Company Gets 510(k), CE Marking for Esophageal ... [FDA News - 19 hours ago]
Boston Scientific to close Doral plant, elimina... [Miami Herald - 21 hours ago]
US EQUITIES WEEK AHEAD: H-P Results, Home Sales... [CNN Money - 23 hours ago]
24 Tech Citizens honored today for generosity [Mass High Tech - 11/20/2009]
TriVascular2 Raises $30 Million [Private Equity HUB - 11/20/2009]
Former Boston Scientific venture captures $30m ... [Clinica - 11/20/2009]
UBS upbeat on medical tech stocks [Financial News USA - 11/20/2009]
FDA Clearance and CE Mark for Boston Scientific... [ASM International - 11/20/2009]
Boston Scientific's WallFlex Fully Covered Esop... [News-Medical.Net - 11/20/2009]
Market Report -- In Play (BSX) [Briefing.com via MSN Money - 11/20/2009]
BRIEF-Boston Scientific announces FDA clearance... [Forbes.com - 11/20/2009]
Boston Scientific Announces FDA Clearance and C... [Earthtimes.org - 11/20/2009]
Boston Scientific (BSX) Receives 510(k) Clearan... [Street Insider - 11/20/2009]
Boston Scientific Announces FDA Clearance and C... [PR Newswire via MSN Money - 11/20/2009]
AHA: Obesity and Smoking Major Risk Factors for... [MedPage Today - 11/20/2009]
US Senate Bill Includes Lower $2 Billion Medica... [CNN Money - 11/19/2009]
The Dimock Center helps Boston's residents — an... [Mass High Tech - 11/19/2009]
2009 Tech Citizenship honoree: Boston Scientifi... [Mass High Tech - 11/19/2009]
Industry, government, academia make work force ... [Mass High Tech - 11/19/2009]
Wall Street News Alert: Market Watch: BOCL - No... [PR-USA.net - 11/19/2009]
Day Two in DC: Can pharma police everything onl... [Medical Marketing And Media - 11/19/2009]
The Cardiac Device Market Outlook for 2010 [Diagnostic & Invasive Cardiology - 11/19/2009]
Optiant Updates PowerChain 6.2 With Features Th... [Street Insider - 11/18/2009]
UBS Upgrades Boston Scientific (BSX) to Buy [Street Insider - 11/18/2009]
BRIEF-RESEARCH ALERT-UBS raises Boston Scientif... [Forbes.com - 11/18/2009]
AHA: New Trumps Old in Comparison of Heart Pumps [MedPage Today - 11/18/2009]
The Future of Stent Technology Highlighted at T... [Diagnostic & Invasive Cardiology - 11/17/2009]
1 2 3 4 5 6 7 8 9 10 ...
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Network
Trends

Blogs

sort by: Date | Relevance
BUY OR SELL-Is Medtronic immune to device secto... [Economy-Finance - 11/18/2009]
* Investors see quarterly results meeting expectations * Views diverge over long-range growth prospects By Susan Kelly CHICAGO, Nov 18 (Reuters) - In a ...
Boston Scientific Sets $296 Million Settlement ... [WSJ.com: Health Blog - 11/06/2009]
Now you see it. Now you don’t. So it goes with Boston Scientific’s third-quarter profit as a result of a settlement agreement with the Justice Department that the ...
Alana B. Elias Kornfeld: TED MED 2009: The Futu... [The Huffington Post Full Blog Feed - 10/28/2009]
Day 2 at TED MED 2009 and the energy is high. This morning's session began with John Abele, the co-founder of the Boston Scientific Corporation, who spoke ...
The Least Helpful Call You Will See Today [Jeff Matthews Is Not Making This Up - 10/21/2009]
The least helpful call you will see today—and there are a number of contestants for that honor, not the least being Leerink Swann’s reduction in price target for ...
Boston Scientific Company Q3 2009 Earnings Call... [Biotech Sector and Stocks Analysis from Seeking ... - 10/21/2009]
Boston Scientific Company (BSX) Q3 2009 Earnings Call October 20, 2009 8:00 am ETComplete Story » ...
1 2 3 4 5 6 7 8 9 10 ...

  •  
  •  
  •